WhatsApp
backNews Article

Indegene Limited Announces Unaudited Consolidated and Standalone Results for Q2 and H1 Ending September 30, 2026

Board meeting on October 29 approves financial results, RSU and ESOP allotments, key resignations, and policy updates

Indegene Limited has approved its unaudited consolidated and standalone financial results for the second quarter and half year ended September 30, 2026. The results underwent a limited review by auditors with an unmodified opinion. The company also announced allotments under its RSU and ESOP schemes, accepted key resignations, and amended its Sexual Harassment Policy in the board meeting held on October 29, 2026.

8 hours ago|INDGN-1.56%
Indegene LimitedINDGNFinancial Results

Indegene Limited

Financial Results

Indegene Limited approved its unaudited consolidated and standalone financial results for the second quarter and half year ended September 30, 2026, alongside approving allotments under RSU and ESOP schemes and key personnel resignations during its board meeting on October 29, 2026.

The Board of Directors reviewed and accepted the unaudited consolidated and standalone financial statements for Q2 and H1 FY 2026-27, accompanied by a limited review report from auditors featuring an unmodified opinion.

Allotments under the company's RSU Scheme 2020 and ESOP Scheme 2020 were approved as part of employee compensation initiatives.

The Board noted resignations from Mr. Mark Francis Dzialga as Non-Executive Non-Independent Director effective October 29, 2026, and Ms. Srishti Ramesh Kaushik as Company Secretary, Compliance Officer, and Key Managerial Personnel effective December 2, 2026, expressing appreciation for their services.

Reconstitution of the Nomination and Remuneration Committee and Investment Committee was approved consequent to Mr. Dzialga's resignation.

An amendment to the Company's Prevention of Sexual Harassment Policy was approved to ensure regulatory compliance and employee welfare.

Highlights

  • Unaudited consolidated and standalone results approved for Q2 and half year ended September 30, 2026.
  • Financial reports underwent limited review with unmodified auditor opinion by Deloitte Haskins & Sells.
  • RSU Scheme 2020 and ESOP Scheme 2020 allotments sanctioned by the Board.
  • Resignation of Non-Executive Director Mr. Mark Francis Dzialga effective October 29, 2026.
  • Resignation of Company Secretary Ms. Srishti Ramesh Kaushik effective December 2, 2026.
  • Nomination and Remuneration Committee and Investment Committee reconstituted following director resignation.

Key Data Snapshot

Reporting periodQuarter and half year ended September 30, 2026
Auditor opinionUnmodified opinion on limited review of financials
Director resignation effective dateOctober 29, 2026
Company Secretary resignation effective dateDecember 2, 2026
Subsidiaries included in consolidated results16 including Indegene Limited (Parent) and subsidiaries in USA, Canada, Germany, Mexico, and others

What happened

  • Indegene Limited's Board approved unaudited standalone and consolidated financial results for Q2 and half year ended September 30, 2026.
  • Limited review report issued by Deloitte Haskins & Sells confirmed compliance with accounting standards with an unmodified opinion.
  • Allotments under RSU Scheme 2020 and ESOP Scheme 2020 for employee benefits were approved.
  • Resignations of Non-Executive Director Mr. Mark Francis Dzialga and Company Secretary Ms. Srishti Ramesh Kaushik were accepted with respective effective dates.
  • Nomination and Remuneration Committee and Investment Committee were reconstituted following director resignation.
  • Amendment to the Prevention of Sexual Harassment Policy was approved by the Board.

Key details

  • Board meeting held on October 29, 2026, started at 6:30 PM IST and concluded at 7:16 PM IST.
  • The consolidated financial results include 16 entities comprising the parent and various subsidiaries, with operations spanning multiple countries.
  • The limited review covered interim financial results prepared under Indian Accounting Standard 34 (Ind AS 34).
  • The company announced reopening of trading window effective November 2, 2026, in compliance with SEBI regulations.
  • Letters of resignation from the departing director and company secretary were enclosed as annexures to the filing.

Regulatory and governance context

  • Filing was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • The amendment to the Prevention of Sexual Harassment Policy is aligned with regulatory compliance requirements.
  • Trading window reopening follows SEBI (Prohibition of Insider Trading) Regulations 2015 and the company's insider trading code.

More News on Financial Results

View all

Latest corporate announcements and market updates in Financial Results.

Top Story
ALIVUS+2.91%9 hours ago

Alivus Life Sciences Posts ₹3,568 Million Net Profit in First Half of FY2026, Q2 Net Profit at ₹1,967 Million

Alivus Life Sciences Limited has reported its unaudited financial results for the second quarter and half year ended September 30, 2026, posting a net profit of ₹1,967 million for the quarter and ₹3,568 million for the half year, supported by revenue growth.

Read Full Story
Top Story
TIMKEN-0.66%9 hours ago

Timken India Limited Achieves Rs 2,311.94 Million Net Profit for First Half of FY 2026-27

Timken India Limited reported a net profit after tax of Rs 2,311.94 million for the half year ended September 30, 2026, with revenue from operations totaling Rs 18,983.82 million, as per its unaudited standalone financial results approved by the Board on October 29, 2026.

Read Full Story
Top Story
DEEPAKNTR+4.40%9 hours ago

Deepak Nitrite Limited Approves Unaudited Financial Results for Q2 and H1 September 2026

Deepak Nitrite Limited's Board approved the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026, with a limited review conducted by Deloitte Haskins & Sells LLP.

Read Full Story
View all news
Indegene Limited Announces Unaudited Consolidated and | Stockk News